Autotaxin expression in NHL
Lymphoma subtype . | No. positive . | Total . | % positive . |
|---|---|---|---|
| Low-grade B-cell NHL | |||
| Follicular lymphoma | 2 | 25 | 8 |
| Chronic lymphocytic lymphoma | 0 | 6 | 0 |
| Mantle cell lymphoma | 1 | 5 | 20 |
| MALT lymphoma | 1 | 1 | 100 |
| High-grade B-cell NHL | |||
| Burkitt lymphoma | 2 | 14 | 14 |
| DLBCL | |||
| Centroblastic and immunoblastic* | 7 | 26 | 27 |
| CD30+/anaplastic* | 12 | 12 | 100 |
| Primary cutaneous | 2 | 5 | 40 |
| Posttransplantation lymphoproliferative disorder | 1 | 1 | 100 |
| T-cell neoplasms | |||
| Peripheral T-cell NHL unspecified | 2 | 4 | 50 |
| Mycosis fungoides | 0 | 1 | 0 |
| NK/T -cell lymphoma (angiocentric) | 0 | 1 | 0 |
| ALCL (null/T-cell type) | 2 | 5 | 40 |
Lymphoma subtype . | No. positive . | Total . | % positive . |
|---|---|---|---|
| Low-grade B-cell NHL | |||
| Follicular lymphoma | 2 | 25 | 8 |
| Chronic lymphocytic lymphoma | 0 | 6 | 0 |
| Mantle cell lymphoma | 1 | 5 | 20 |
| MALT lymphoma | 1 | 1 | 100 |
| High-grade B-cell NHL | |||
| Burkitt lymphoma | 2 | 14 | 14 |
| DLBCL | |||
| Centroblastic and immunoblastic* | 7 | 26 | 27 |
| CD30+/anaplastic* | 12 | 12 | 100 |
| Primary cutaneous | 2 | 5 | 40 |
| Posttransplantation lymphoproliferative disorder | 1 | 1 | 100 |
| T-cell neoplasms | |||
| Peripheral T-cell NHL unspecified | 2 | 4 | 50 |
| Mycosis fungoides | 0 | 1 | 0 |
| NK/T -cell lymphoma (angiocentric) | 0 | 1 | 0 |
| ALCL (null/T-cell type) | 2 | 5 | 40 |
DLBCL indicates diffuse large B-cell lymphoma; ALCL, anaplastic large-cell lymphoma.
Morphologic variants of DLBCL.